All times are listed in CEST (Central European Summer Time)

 

Browsing Over 476 Presentations

Sort By
Mirati Therapeutics, Inc. - New frontiers in the treatment of advanced NSCLC (ID 40) Industry Satellite Symposium

Chair’s introduction

Lecture Time
11:30 - 11:35
Speakers
  • S. Peters (Lausanne, Switzerland)
Authors
  • S. Peters (Lausanne, Switzerland)
Session Name
Mirati Therapeutics, Inc. - New frontiers in the treatment of advanced NSCLC (ID 40)
Date
Wed, 29.03.2023
Time
11:30 - 13:00
Room
Auditorium 2
Mirati Therapeutics, Inc. - New frontiers in the treatment of advanced NSCLC (ID 40) Industry Satellite Symposium

Treatment landscape for advanced NSCLC: Where are we now?

Lecture Time
11:35 - 11:55
Speakers
  • J. Wolf (Cologne, Germany)
Authors
  • J. Wolf (Cologne, Germany)
Session Name
Mirati Therapeutics, Inc. - New frontiers in the treatment of advanced NSCLC (ID 40)
Date
Wed, 29.03.2023
Time
11:30 - 13:00
Room
Auditorium 2
Mirati Therapeutics, Inc. - New frontiers in the treatment of advanced NSCLC (ID 40) Industry Satellite Symposium

How may we overcome resistance to CPI therapy?

Lecture Time
11:55 - 12:15
Speakers
  • S. Popat (London, United Kingdom)
Authors
  • S. Popat (London, United Kingdom)
Session Name
Mirati Therapeutics, Inc. - New frontiers in the treatment of advanced NSCLC (ID 40)
Date
Wed, 29.03.2023
Time
11:30 - 13:00
Room
Auditorium 2
Mirati Therapeutics, Inc. - New frontiers in the treatment of advanced NSCLC (ID 40) Industry Satellite Symposium

Targeting KRASG12C: Kick-starting a KRAS revolution

Lecture Time
12:15 - 12:45
Speakers
  • S. Peters (Lausanne, Switzerland)
Authors
  • S. Peters (Lausanne, Switzerland)
Session Name
Mirati Therapeutics, Inc. - New frontiers in the treatment of advanced NSCLC (ID 40)
Date
Wed, 29.03.2023
Time
11:30 - 13:00
Room
Auditorium 2
Mirati Therapeutics, Inc. - New frontiers in the treatment of advanced NSCLC (ID 40) Industry Satellite Symposium

Q&A and summary

Lecture Time
12:45 - 13:00
Session Name
Mirati Therapeutics, Inc. - New frontiers in the treatment of advanced NSCLC (ID 40)
Date
Wed, 29.03.2023
Time
11:30 - 13:00
Room
Auditorium 2
Keynote lecture

Welcome to the European Lung Cancer Congress 2023 by the Scientific Co-Chairs

Lecture Time
13:30 - 13:35
Speakers
  • M. Reck (Grosshansdorf, Germany)
Session Name
Opening session and Heine H. Hansen Award 2023 (ID 63)
Room
Auditorium 1
Date
Wed, 29.03.2023
Time
13:30 - 14:15
Authors
  • M. Reck (Grosshansdorf, Germany)
Keynote lecture

Mesothelioma treatment: From hopeless to hopeful

Lecture Time
13:50 - 14:15
Speakers
  • P. Baas (Amsterdam, Netherlands)
Session Name
Opening session and Heine H. Hansen Award 2023 (ID 63)
Room
Auditorium 1
Date
Wed, 29.03.2023
Time
13:30 - 14:15
Authors
  • P. Baas (Amsterdam, Netherlands)
Keynote lecture

Presentation of 2020-2021-2022 Heine H. Hansen Awardees (Profs. Fiona Blackhall, Johan Vansteenkiste and Fred R. Hirsch)

Lecture Time
13:35 - 13:45
Speakers
  • H. Wakelee (Stanford, United States of America)
Session Name
Opening session and Heine H. Hansen Award 2023 (ID 63)
Room
Auditorium 1
Date
Wed, 29.03.2023
Time
13:30 - 14:15
Authors
  • H. Wakelee (Stanford, United States of America)
Keynote lecture

Introduction to the Heine H. Hansen Award 2023

Lecture Time
13:45 - 13:50
Speakers
  • S. Peters (Lausanne, Switzerland)
Session Name
Opening session and Heine H. Hansen Award 2023 (ID 63)
Room
Auditorium 1
Date
Wed, 29.03.2023
Time
13:30 - 14:15
Authors
  • S. Peters (Lausanne, Switzerland)
Educational session

Insights in biology

Lecture Time
14:30 - 14:50
Speakers
  • P. Baas (Amsterdam, Netherlands)
Session Name
Mesothelioma: From biology to novel treatment strategies (ID 16)
Room
Auditorium 4
Date
Wed, 29.03.2023
Time
14:30 - 16:00
Authors
  • P. Baas (Amsterdam, Netherlands)
Educational session

State of the art clinical treatment / Frontline studies

Lecture Time
14:50 - 15:10
Speakers
  • A. S. Tsao (Houston, United States of America)
Session Name
Mesothelioma: From biology to novel treatment strategies (ID 16)
Room
Auditorium 4
Date
Wed, 29.03.2023
Time
14:30 - 16:00
Authors
  • A. S. Tsao (Houston, United States of America)
Educational session

Optimal first-line therapy for extensive-stage SCLC

Lecture Time
14:30 - 14:50
Speakers
  • C. M. Rudin (New York, United States of America)
Session Name
State of the art for small cell lung cancer: Unraveling recent data (ID 17)
Room
Auditorium 2
Date
Wed, 29.03.2023
Time
14:30 - 16:00
Authors
  • C. M. Rudin (New York, United States of America)